Ronak Tilvawala received her bachelor’s degree in pharmaceutical sciences in 2007 from India. She received her Ph.D. degree in chemistry in 2014 from Wesleyan University, USA. From 2014 to 2016, she worked as a postdoctoral fellow at Texas A & M medical school where she developed novel biosensors for the detection of early-stage tuberculosis. In 2016, she moved to UMass medical school, where she developed a novel chemo proteomic approach to detect citrullinated proteins from biological samples. In 2020, she joined the department of Molecular Biosciences at the University of Kansas as an Assistant Professor. The current projects are focused on mainly two areas: 1) understanding how protein citrullination disrupts the regulation of key protease cascades leading to thrombosis and inflammation in multiple pathologies; and 2) understanding how viral proteases interfere with host protease cascades to invade into the host system. She has coauthored more than 18 publications. e
Pharmaceutical Sciences
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
